Board of Directors of the Company has met today and inter alia transacted the following business. 1.Taken on record and approved the Un-audited standalone and consolidated financial results of the Company for the quarter and half year ended 30.09.2023. A copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed with this intimation. 2. Approved the allotment of 1,18,500 Equity shares to the employees of the Company who has exercised the employee stock options vested on them. 3. Approved the grant of 1,83,500 stock options to the eligible employees of the Company from 'Bal Pharma Ltd-Employee stock option plan-2014'. The meeting of the Board has commenced at 4.45 p.m. and concluded at 5.40 p.m on Wednesday, 8th November 2023.